Equity Transaction, Put Option Settlement, Consideration Transferred

No definition available.

Name:	curlf_EquityTransactionPutOptionSettlementConsiderationTransferred
Namespace Prefix:	curlf_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Equity Transaction, Put Option Settlement, Consideration Transferred, Cash

+ References

No definition available.

+ Details

Name:	curlf_EquityTransactionPutOptionSettlementConsiderationTransferredCash
Namespace Prefix:	curlf_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Equity Transaction, Put Option Settlement, Consideration Transferred, Deferred

+ References

No definition available.

+ Details

Name:	curlf_EquityTransactionPutOptionSettlementConsiderationTransferredDeferred
Namespace Prefix:	curlf_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Equity Transaction, Put Option Settlement, Consideration Transferred, Deferred, Interest Rate

+ References

No definition available.

+ Details

Name:	curlf_EquityTransactionPutOptionSettlementConsiderationTransferredDeferredInterestRate
Namespace Prefix:	curlf_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Equity Transaction, Put Option Settlement, Consideration Transferred, Deferred, Number Of Installments

+ References

No definition available.

+ Details

Name:	curlf_EquityTransactionPutOptionSettlementConsiderationTransferredDeferredNumberOfInstallments
Namespace Prefix:	curlf_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

- Definition

Equity Transaction, Put Option Settlement, Consideration Transferred, Equity Interest Issued

+ References

No definition available.

+ Details

Name:	curlf_EquityTransactionPutOptionSettlementConsiderationTransferredEquityInterestIssued
Namespace Prefix:	curlf_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Equity Transaction, Put Option Settlement, Trigger Period

+ References

No definition available.

+ Details

Name:	curlf_EquityTransactionPutOptionSettlementTriggerPeriod
Namespace Prefix:	curlf_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)(5)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)(3)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)(4)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (a)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 815
-SubTopic 40
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Subparagraph (e)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480237/815-40-50-5

+ Details

Name:	us-gaap_OptionIndexedToIssuersEquityLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=curlf_Four20PharmaGmbhMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

10-Q Redeemable non-controlling interest (Details) € in Millions		1 Months Ended
	Apr. 30, 2026 EUR (€) installment	Sep. 30, 2022	Feb. 23, 2026	Dec. 31, 2025	Dec. 31, 2024
Option Indexed to Issuer's Equity [Line Items]
Put option settlement, trigger period		2 years
Subsequent events
Option Indexed to Issuer's Equity [Line Items]
Put option settlement, consideration transferred	€ 76.5
Put option settlement, consideration transferred, cash	43.0
Put option settlement, consideration transferred, deferred	12.2
Put option settlement, consideration transferred, equity	€ 21.3
Put option settlement, consideration transferred, deferred, number of installment \| installment	2
Put option settlement, consideration transferred, deferred, interest rate	6.00%
Four20 Pharma GmbH
Option Indexed to Issuer's Equity [Line Items]
Ownership interest by minority shareholders			45.00%	45.00%	45.00%
Four20 Pharma GmbH \| Subsequent events
Option Indexed to Issuer's Equity [Line Items]
Ownership interest by minority shareholders			45.00%